Research on the Role of Probiotics in Human Intestinal Health
ConditionIntestinal Microbiota
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorWecare Probiotics Co., Ltd.
About this trial
Evaluate the efectiveness and safety of Bifidobacterium bifidum BBi32 as a food supplement compared to a placebo in improving intestinal andimmune functions in healthy adults.
Eligibility criteria
Qualifiers
Willing to attend 3 follow-up visits during the intervention period
Agree to provide blood, urine, and stool samples twice during the intervention period
Good eyesight, able to read and write, and capable of wearing glasses if needed
Good hearing and able to fully comprehend all instructions during the intervention
Disqualifiers
Presence of digestive diseases, particularly gastrointestinal disorders (e.g., celiac disease, ulcerative colitis, Crohn's disease)
History of serious neurological conditions (e.g., epilepsy, stroke, severe head trauma, meningitis within the last 10 years, brain surgery, brain tumor, or prolonged coma-not including general anesthesia)
History of or currently receiving treatment for mental health disorders such as alcohol/drug/substance abuse, schizophrenia, psychosis, or bipolar disorder
Currently taking medication for depression or low mood
Trial design
Treatments tested in this trial
- Probiotic
- Placebo
Treatment groups
45 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov